Cargando…
Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen
A neutralizing monoclonal antibody of the budded phenotype of Autographa californica nuclear polyhedrons virus did not react with the occluded form of the virus as determined by neutralization, ELISA, and indirect immunoperoxidase staining. The antibody did react with the surface of infected cells i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131201/ https://www.ncbi.nlm.nih.gov/pubmed/18639808 http://dx.doi.org/10.1016/0042-6822(84)90401-X |
_version_ | 1783517184700448768 |
---|---|
author | Volkman, Loy E. Goldsmith, Phyllis A. Hess, Roberta T. Faulkner, Peter |
author_facet | Volkman, Loy E. Goldsmith, Phyllis A. Hess, Roberta T. Faulkner, Peter |
author_sort | Volkman, Loy E. |
collection | PubMed |
description | A neutralizing monoclonal antibody of the budded phenotype of Autographa californica nuclear polyhedrons virus did not react with the occluded form of the virus as determined by neutralization, ELISA, and indirect immunoperoxidase staining. The antibody did react with the surface of infected cells in the prepolyhedra stage of cytopathic effect, the period of active virus budding. Immunoelectron microscopy indicated the antigen(s) reactive with the neutralizing antibody was present all around the viral envelope, but was more highly concentrated at the end with peplomers. Four proteins were immunoprecipitated from solubilized, radiolabeled budded virus preparations with the monoclonal antibody. The major protein had a molecular weight of approximately 64,000, while the other three were approximately 127,000, 59,000, and 49,000. All four proteins could be labeled with N-acetyl-d-[1-(3)H]glucosamine. This glycosylation reaction could be inhibited by tunicamycin. |
format | Online Article Text |
id | pubmed-7131201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1984 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71312012020-04-08 Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen Volkman, Loy E. Goldsmith, Phyllis A. Hess, Roberta T. Faulkner, Peter Virology Article A neutralizing monoclonal antibody of the budded phenotype of Autographa californica nuclear polyhedrons virus did not react with the occluded form of the virus as determined by neutralization, ELISA, and indirect immunoperoxidase staining. The antibody did react with the surface of infected cells in the prepolyhedra stage of cytopathic effect, the period of active virus budding. Immunoelectron microscopy indicated the antigen(s) reactive with the neutralizing antibody was present all around the viral envelope, but was more highly concentrated at the end with peplomers. Four proteins were immunoprecipitated from solubilized, radiolabeled budded virus preparations with the monoclonal antibody. The major protein had a molecular weight of approximately 64,000, while the other three were approximately 127,000, 59,000, and 49,000. All four proteins could be labeled with N-acetyl-d-[1-(3)H]glucosamine. This glycosylation reaction could be inhibited by tunicamycin. Published by Elsevier Inc. 1984-03 2004-06-10 /pmc/articles/PMC7131201/ /pubmed/18639808 http://dx.doi.org/10.1016/0042-6822(84)90401-X Text en Copyright © 1984 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Volkman, Loy E. Goldsmith, Phyllis A. Hess, Roberta T. Faulkner, Peter Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen |
title | Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen |
title_full | Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen |
title_fullStr | Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen |
title_full_unstemmed | Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen |
title_short | Neutralization of budded Autographa californica NPV by a monoclonal antibody: Identification of the target antigen |
title_sort | neutralization of budded autographa californica npv by a monoclonal antibody: identification of the target antigen |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131201/ https://www.ncbi.nlm.nih.gov/pubmed/18639808 http://dx.doi.org/10.1016/0042-6822(84)90401-X |
work_keys_str_mv | AT volkmanloye neutralizationofbuddedautographacalifornicanpvbyamonoclonalantibodyidentificationofthetargetantigen AT goldsmithphyllisa neutralizationofbuddedautographacalifornicanpvbyamonoclonalantibodyidentificationofthetargetantigen AT hessrobertat neutralizationofbuddedautographacalifornicanpvbyamonoclonalantibodyidentificationofthetargetantigen AT faulknerpeter neutralizationofbuddedautographacalifornicanpvbyamonoclonalantibodyidentificationofthetargetantigen |